Acceleron Pharma Inc. EBITDA 2013-2021 | XLRN
Acceleron Pharma Inc. ebitda from 2013 to 2021. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Acceleron Pharma Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2020 | $-163 |
| 2019 | $-133 |
| 2018 | $-121 |
| 2017 | $-107 |
| 2016 | $-64 |
| 2015 | $-60 |
| 2014 | $-54 |
| 2013 | $8 |
| 2012 | $-27 |
| 2011 | $42 |
| Acceleron Pharma Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2021-09-30 | $-69 |
| 2021-06-30 | $-63 |
| 2021-03-31 | $-63 |
| 2020-12-31 | $-57 |
| 2020-09-30 | $-38 |
| 2020-06-30 | $-18 |
| 2020-03-31 | $-51 |
| 2019-12-31 | $-25 |
| 2019-09-30 | $-48 |
| 2019-06-30 | $-20 |
| 2019-03-31 | $-40 |
| 2018-12-31 | $-36 |
| 2018-09-30 | $-29 |
| 2018-06-30 | $-29 |
| 2018-03-31 | $-27 |
| 2017-12-31 | $-28 |
| 2017-09-30 | $-25 |
| 2017-06-30 | $-29 |
| 2017-03-31 | $-25 |
| 2016-12-31 | $-21 |
| 2016-09-30 | $-20 |
| 2016-06-30 | $-20 |
| 2016-03-31 | $-4 |
| 2015-12-31 | $-18 |
| 2015-09-30 | $-14 |
| 2015-06-30 | $-13 |
| 2015-03-31 | $-16 |
| 2014-12-31 | $-14 |
| 2014-09-30 | $-11 |
| 2014-06-30 | $-17 |
| 2014-03-31 | $-12 |
| 2013-12-31 | $-3 |
| 2013-09-30 | $-7 |
| 2013-06-30 | $15 |
| 2013-03-31 | $3 |
| 2012-09-30 | $-7 |
